Testosterone Pellet 200 mg Recalled for Glass Particle Contamination
BSO LLC is recalling compounded testosterone pellets nationwide because glass particles were found in vials. Affected lot numbers are 20250207@1 and 20250228@1 (expiration 1/31/2026).
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II recall of a drug product with a confirmed physical hazard (glass particles) that could cause harm if injected. Class II recalls with a risk of serious injury or harm to patients warrant a score of 4 under the rubric.
Plain-English summary
BSO LLC is recalling compounded testosterone pellets (200 mg, NDC 70168-0125-01) distributed nationwide in the USA. The recall was initiated because glass particles were found in pellet vials.
The affected product is a compounded testosterone pellet for subcutaneous use, dispensed for office or RX use only. Lot numbers 20250207@1 and 20250228@1 are affected, both with expiration date 1/31/2026. Approximately 1,974 vials have been distributed.
Patients and healthcare providers who have received this product should stop use. Affected vials should be returned to BSO LLC (Belmar Select Outsources, 12860 W. Cedar Drive #211, Lakewood, CO 80228) or to the dispensing healthcare provider. For more information, patients should contact their healthcare provider.
The recalled product
- Product
- TESTOSTERONE PELLET 200 mg (with Cholesterol </=2%), 1 Pellet for Subcutaneous Use, This is a Compounded Drug, Not for Resale, RX or Office Use Only, Belmar Select Outsources, 12860 W. Cedar Drive #211, Lakewood, CO 80228, NDC: 70168-0125-01
- Manufacturer
- BSO LLC
- Category
- Drug — Compounded Testosterone
- Affected units
- 1,974
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot 20250207@1
- exp 1/31/2026
- Lot 20250228@1
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 5 recalled by BSO LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · BSO LLC
See all →- ModerateTestosterone Pellet 100 mg recalled due to glass particle contamination
FDA (Drugs) · 2025-05-14
- SevereTestosterone Pellet 200 mg Recalled for Glass Particulate Matter
FDA (Drugs) · 2025-05-14
- SevereTestosterone Pellet 200 mg Recalled Due to Glass Particles
FDA (Drugs) · 2025-05-14
- HighTestosterone Pellet 200 mg Recalled for Glass Particulate Matter
FDA (Drugs) · 2025-05-14
Same hazard · glass particles
See all →- SevereFresenius Kabi Recalls Tyenne Injection Due to Glass Particles
FDA (Drugs) · 2026-09-02
- HighDexamethasone and moxifloxacin injection recalled over glass-like particulate matter
FDA (Drugs) · 2026-01-14
- HighTri-Moxi intraocular injection recalled over glass-like particulate matter
FDA (Drugs) · 2026-01-14
- HighIntraocular injection syringes recalled over glass-like particulate matter
FDA (Drugs) · 2026-01-14
- HighProgesterone Injection Recalled Nationwide for Glass Particulate Matter
FDA (Drugs) · 2025-01-15